Amgen’s Bkemv is the first interchangeable biosimilar to Soliris to treat certain rare diseases. The treatment of patients ...
, opens new tab rare blood disorder treatment Soliris. Amgen's drug will be marketed under the name Bkemv. Biosimilars are close copies of complex biological drugs. The approval comes with a black ...
AbbVie ABBV dosed the first patient with ABBV-383, an investigational BCMA-CD3-targeted bispecific antibody, in the phase III ...
The FDA has made two approvals this week: the first interchangeable biosimilar of Soliris and another indication for Breyanzi ...
Analyst Salim Syed from Mizuho Securities maintained a Hold rating on Amgen (AMGN – Research Report) and keeping the price target at ...
The U.S. Food and Drug Administration on Thursday approved a new drug to treat patients with an advanced form of deadly lung ...
Today, the U.S. Food and Drug Administration approved Bkemv (eculizumab-aeeb) as the first interchangeable biosimilar to Soliris (eculizumab) to treat certain rare diseases. Bkemv is approved for the ...
A team at King’s College London has developed a “drug delivery cage” that can be filled with chemotherapy drugs.
The European Commission approved Bristol Myers Squibb’s Opdivo combination therapy for urothelial cancer based on Phase III ...
Latest health news includes Louisiana's reclassification of abortion pills as controlled substances, the effectiveness of ...
The facility, which will be the drugmaker's first end-to-end ADC production site, will be supported by the Singapore Economic Development Board. The company did not provide details on the possible ...